< Back to companies
SEVEN POINT ONE

SEVEN POINT ONE

Seattle, Washington, United States

SEVEN POINT ONE is a healthcare startup that specializes in cognitive assessment technology aimed at early detection of cognitive decline, particularly in seniors. Its flagship product, AlzWIN, is an AI-powered tool designed to evaluate brain health through a simple and fast speech-based test, which can be conducted in just one minute. AlzWIN is accessible for anyone, anywhere, and was developed based on findings from clinical trials confirming its accuracy in identifying individuals at high risk for dementia. The company adheres to high-quality standards, being certified with ISO 13485 for medical devices and GMP. SEVEN POINT ONE aims to improve brain health management by providing tools that offer medical, emotional, and social benefits, enhancing the overall quality of life for users.

Share
Shareable draft
Get Involved in SEVEN POINT ONE

Company Info

Founded
2017
Website
sevenptone.com/

Categories

Alzheimer(s) DiseaseClinical TrialsDiagnostics & Monitoring

Disease Areas

Technologies

Clinical TrialsDiagnostic Decision Support
Only accessible to MedStartr community members. Join now

What do you think of SEVEN POINT ONE?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in SEVEN POINT ONE
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free